NeoGenomics Laboratories

NeoGenomics Laboratories, Inc. is a publicly traded clinical laboratory company based in Fort Myers, Florida, specializing in cancer genetics diagnostic testing. Founded in 2001, it has established itself as a global leader in oncology-focused laboratory testing, operating CAP-accredited and CLIA-certified laboratories across the United States and Europe. The company employs over 2,200 staff, including more than 120 MDs and PhDs, and serves around 4,400 medical sites, conducting over 1.7 million cancer-related tests annually. NeoGenomics offers a comprehensive range of oncology testing services, including cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC), anatomic pathology, and molecular genetics with next-generation sequencing (NGS). The company supports a diverse customer base, including pathologists, oncologists, academic medical centers, and pharmaceutical firms involved in clinical trials. Its mission is to enhance cancer diagnosis and treatment through innovative molecular and genomic technologies, facilitating personalized medicine approaches for better patient outcomes.